Ren-Jay Shei

Ren-Jay Shei is a Senior Medical Science Liaison at SpringWorks Therapeutics since June 2023, having previously served as a Medical Science Liaison at Coherus BioSciences from September 2021 to June 2023, where responsibilities included managing a portfolio of FDA-approved and investigational oncology products. Key achievements included leading studies on combination therapies for advanced tumors and providing integral support for clinical and research initiatives. Prior experience includes a Medical Science Liaison role at Mallinckrodt Pharmaceuticals, where Ren-Jay Shei contributed to research on INOmax® in neonates and led multiple business development initiatives. Academic credentials include a Ph.D. in Human Performance - Exercise Physiology, as well as master's and bachelor's degrees in related fields from Indiana University Bloomington, coupled with experience as an Associate Instructor and postdoctoral scholar focused on cystic fibrosis research.